The global TIL Cell Therapy market size is predicted to grow from US$ 138 million in 2025 to US$ 1107 million in 2031; it is expected to grow at a CAGR of 41.5% from 2025 to 2031.

Tumor-infiltrating lymphocyte (TIL) therapy is an innovative new cancer treatment. TIL cell therapy is a type of cellular immunotherapy that can help your immune system kill cancer cells when other treatments have failed.

United States market for TIL Cell Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for TIL Cell Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for TIL Cell Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key TIL Cell Therapy players cover Iovance Biotherapeutics, Achilles Therapeutics (Pipeline), InstilBio (Pipeline), Obsidian (Pipeline), Turnstone (Pipeline), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information) newest research report, the ?TIL Cell Therapy Industry Forecast? looks at past sales and reviews total world TIL Cell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected TIL Cell Therapy sales for 2025 through 2031. With TIL Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TIL Cell Therapy industry.

This Insight Report provides a comprehensive analysis of the global TIL Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on TIL Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global TIL Cell Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TIL Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TIL Cell Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of TIL Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Single TIL Therapy
    Combination TIL Therapy

Segmentation by Application:

    Melanoma
    Non-small Cell Carcinoma
    Head and Neck Squamous Cell Carcinoma
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Iovance Biotherapeutics
    Achilles Therapeutics (Pipeline)
    InstilBio (Pipeline)
    Obsidian (Pipeline)
    Turnstone (Pipeline)
    Shenzhen Shali Biotechnology (Pipeline)
    Cellular Biomedicine Group (Pipeline)
    Shanghai Junsai Biotechnology (Pipeline)